July 31, 2023
Payers | Tea Leaves
  • A new study asserts that while payers should cover telehealth, where these services are the most valuable still requires investigation. The Centers for Medicare & Medicaid Services (CMS) made the rules about telehealth usage more flexible during the COVID-19 pandemic, and some lawmakers want to make those changes permanent. But according to research from the University of Texas, that should not mean giving providers complete approval freedom using the new technology, nor should payers cover all uses of telehealth. (Article here)
  • The U.S. Chamber of Commerce, one of the largest lobbying groups in the country, filed a motion Wednesday for a preliminary injunction to block the implementation of the Medicare Drug Price Negotiation program established by the Inflation Reduction Act (IRA), which is currently facing an onslaught of legal challenges. The Chamber filed a lawsuit challenging the constitutionality of the program last month, claiming it violated the First, Fifth, and Eighth Amendments. This suit was one of several filed by drug industry professionals, including the trade group PhRMA, Merck & Co., and Bristol Myers Squibb. (Article here)